Holen Sie sich die Stockscreener-App
41.96
4.04%
1.63
Handel nachbörslich:
41.96
Schlusskurs vom Vortag:
$40.33
Offen:
$40.23
24-Stunden-Volumen:
150.95K
Relative Volume:
1.17
Marktkapitalisierung:
$524.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.59%
1M Leistung:
+12.13%
6M Leistung:
-17.56%
1J Leistung:
+0.00%
1-Tages-Spanne:
$39.25
$43.05
1-Wochen-Bereich:
$38.56
$44.75
52-Wochen-Spanne:
$15.19
$53.00
Neurogene Inc Stock (NGNE) Company Profile
Firmenname
Neurogene Inc
Sektor
Branche
Telefon
(877) 237-5020
Adresse
535 W 24TH STREET, NEW YORK
Neurogene Inc Aktie (NGNE) Neueste Nachrichten
Neurogene Inc. (NASDAQ:NGNE) Stake Raised by Driehaus Capital Management LLC - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Rhumbline Advisers Invests $491,000 in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene (NASDAQ:NGNE) Trading Up 8.2% - MarketBeat
Closing Bell Recap: Neurocrine Biosciences, Inc. (NBIX) Ends at 116.49, Reflecting a -1.07 Downturn - The Dwinnex
Nebius to invest more than USD 1 billion to build AI infrastructure in Europe - sharewise
Renaissance Technologies LLC Raises Holdings in N-able, Inc. (NYSE:NABL) - Defense World
XTX Topco Ltd Sells 4,464 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Rhumbline Advisers Has $721,000 Stock Holdings in NETGEAR, Inc. (NASDAQ:NTGR) - Defense World
Raffles Associates LP Has $3.36 Million Holdings in NB Bancorp, Inc. (NASDAQ:NBBK) - Defense World
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING - WV News
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by American Century Companies Inc. - Defense World
Integral Health Asset Management LLC Buys New Shares in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
70,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Purchased by Integral Health Asset Management LLC - Defense World
NTAP (Netapp Inc) may reap gains as insiders became active recently - Knox Daily
1832 Asset Management L.P. Increases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Ensign Peak Advisors Inc Increases Holdings in NetApp, Inc. (NASDAQ:NTAP) - Defense World
Avoro Capital Advisors LLC Makes New Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Hollencrest Capital Management Buys New Stake in NetApp, Inc. (NASDAQ:NTAP) - Defense World
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by Amalgamated Bank - Defense World
Bank of New York Mellon Corp Purchases New Stake in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Bank of New York Mellon Corp Takes $1.11 Million Position in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
(NBIX) Trading Advice - Stock Traders Daily
Promethos Capital LLC Invests $107,000 in NetApp, Inc. (NASDAQ:NTAP) - Defense World
10,295 Shares in Neuberger Berman Next Generation Connectivity Fund Inc. (NYSE:NBXG) Purchased by Carolinas Wealth Consulting LLC - Defense World
2,056 Shares in NetApp, Inc. (NASDAQ:NTAP) Purchased by Waterloo Capital L.P. - Defense World
Quest Partners LLC Invests $55,000 in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene (NASDAQ:NGNE) Stock Price Up 4.8% - MarketBeat
Neurogene (NASDAQ:NGNE) Shares Down 2.7% - MarketBeat
Rett Syndrome Market Expected to Experience Major Growth - openPR
Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Buy” from Analysts - Defense World
Investors in cash trouble should check out Neurogene Inc (NGNE) - SETE News
Neurogene's (NASDAQ:NGNE) Earnings Might Be Weaker Than You Think - Yahoo Finance
Q3 2024 Earnings Forecast for Neurogene Inc. (NASDAQ:NGNE) Issued By HC Wainwright - Defense World
Q3 2024 Earnings Forecast for Neurogene Inc. (NASDAQ:NGNE) Issued By HC Wainwright - MarketBeat
Neurogene stock holds Outperform with steady target on RMAT designation - Investing.com
Neurogene stock holds Outperform with steady target on RMAT designation By Investing.com - Investing.com Canada
Neurogene stock holds Outperform with steady target on RMAT designation By Investing.com - Investing.com UK
HC Wainwright Lowers Neurogene (NASDAQ:NGNE) Price Target to $49.00 - MarketBeat
Neurogene’s NGN-401 Shows Promise for Rett Syndrome - TipRanks
Neurogene’s NGN-401 Wins Key FDA Designation - TipRanks
HC Wainwright Cuts Neurogene (NASDAQ:NGNE) Price Target to $49.00 - Defense World
Vanguard Group Inc. Increases Position in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Vanguard Group Inc. Buys 457,062 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene: Q2 Earnings Snapshot - San Francisco Chronicle
Neurogene Reports Second Quarter 2024 Financial Results and Highlights Recent Updates - businesswire.com
Neurogene Reports Second Quarter 2024 Financial Results and Highlights Recent Updates - Yahoo Finance
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Neurogene Announces RMAT Designation for NGN-401 Investigational Gene Therapy for Rett Syndrome - Lelezard
Finanzdaten der Neurogene Inc-Aktie (NGNE)
Es liegen keine Finanzdaten für Neurogene Inc (NGNE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):